Street Signs


  • JetBlue pilots vote to join union     Tuesday, 22 Apr 2014 | 2:46 PM ET

    Seventy percent of the JetBlue pilots have voted to join ALPA, reports CNBC's Phil LeBeau.

  • Adjusted earnings abuse?     Tuesday, 22 Apr 2014 | 2:41 PM ET

    Robert Olstein, Olstein Capital Management, and Herb Greenberg, CNBC contributor, discuss whether some companies are abusing how they report quarterly results.

  • Einhorn's new course     Tuesday, 22 Apr 2014 | 2:31 PM ET

    Sandy Villere, Villere Funds, shares his thoughts on Greenlight Capital's new stake in Conn's.

  • Earnings squad: 3 stocks to watch     Tuesday, 22 Apr 2014 | 2:24 PM ET

    CNBC's "Earnings Squad," has a look at three names to watch before they report earnings.

  • Better to rent or own?     Tuesday, 22 Apr 2014 | 2:17 PM ET

    Jed Kolko, Trulia chief economist, discusses whether home ownership is the best long-term investment for most Americans.

  • Biggest threat to housing     Tuesday, 22 Apr 2014 | 2:15 PM ET

    CNBC's Diana Olick takes a look at what's prompting the slump in existing home sales.

  • Next big pharma target     Tuesday, 22 Apr 2014 | 2:04 PM ET

    CNBC's Meg Tirrell; Herb Greenberg, CNBC contributor, and Arindam Nag, Mergermarket, discuss potential takeover targets in the pharmaceutical space.

  • Keystone delay about politics: Shell ex-president Monday, 21 Apr 2014 | 6:51 PM ET
    Pipe is stacked at the southern site of the Keystone XL pipeline in Cushing, Oklahoma.

    The latest delay in the Keystone XL pipeline is all about politics, and not about the reality of pipelines, said John Hofmeister.

  • Forget income equality—this is Hollywood! Tuesday, 22 Apr 2014 | 7:00 AM ET

    The Lefty mayors of NY and LA talk about income equality but when it comes to Hollywood and taxes, they're starry-eyed, says Jake Novak.

  • Economic impact from film & TV     Monday, 21 Apr 2014 | 2:54 PM ET

    "Captain America: The Winter Soldier" was filmed in Cleveland and created 2,800 jobs and contributed $35 million to the state of Ohio. Joe Henchman, Tax Foundation, and Douglas Steiner, Steiner Studios Chairman, discuss state tax credits.

  • Enhanced security at Boston Marathon     Monday, 21 Apr 2014 | 2:49 PM ET

    CNBC's Scott Cohn reports from Boston on the high level of support, as well as security at this year's Boston Marathon.

  • Outlook for wearable tech     Monday, 21 Apr 2014 | 2:45 PM ET

    Discussing a report Nike fired its entire FuelBand crew, and when wearables will be embraced, with Lauren Goode, Re/code tech reporter.

  • Reports indicate Ford is said to name Mark Fields as the next CEO of the auto company, with CNBC's Phil LeBeau.

  • Earnings Squad: Netflix, McDonald's & more     Monday, 21 Apr 2014 | 2:25 PM ET

    What to expect from the earnings of Netflix, AK Steel, McDonald's and Simon Property Group, with CNBC's Melissa Lee, Courtney Reagan and Dominic Chu.

  • Political battle over Keystone: Pro     Monday, 21 Apr 2014 | 2:19 PM ET

    Discussing another delay for the Keystone XL pipeline, and the politics involved in moving the project forward, with John Hofmeister, former Shell Oil president.

  • Keystone XL decision delayed     Monday, 21 Apr 2014 | 2:17 PM ET

    Supporters of the Keystone Pipeline say it is critical to the North American oil boom, reports CNBC's Jackie DeAngelis. The Obama administration has added an additional delay in the program.

  • Focus on large-cap, diversified biotech: Pro     Monday, 21 Apr 2014 | 2:09 PM ET

    Discussing the pullback in biotech, with Paul Hickey, Bespoke Investment Group.

  • Sarepta Therapeutics CEO Chris Garabedian discusses the prospects for what he calls a "potential accelerated approval" for its Duchenne muscular dystrophy drug Eteplirsen.

  • Sarepta muscle drug faces challenges     Monday, 21 Apr 2014 | 2:04 PM ET

    Sarepta Therapeutics is developing a drug for Duchenne muscular dystrophy. Its CEO Chris Garabedian discusses challenges the drug Eteplirsen has faced before the FDA.

  • Sarepta shares up 58%; FDA to review its drug Monday, 21 Apr 2014 | 6:55 AM ET
    A patient with Duchenne muscular dystrophy controls a motorized wheelchair. DMD afflicts about 1 in 3,500 boys worldwide.

    Sarepta Therapeutics got the go-ahead to file for approval of its experimental drug for Duchenne muscular dystrophy.

About Street Signs

  • "Street Signs" airs live 2-3pm ET, Monday-Friday from CNBC Global Headquarters. The show is must see TV for savvy investors looking to capitalize on opportunities beyond the headlines and the herd mentality. Brian Sullivan and Amanda Drury read the signs on Wall Street everyday for the under-the-radar stocks and market trends to make you money.

Contact Street Signs

  • Showtimes

    United States
    Monday - Friday 2:00P ET
    Monday - Friday 20:00 CET
    Tuesday - Saturday 02:00 SIN/HK
    Tuesday - Saturday 04:00 SYD
    New Zealand
    Tuesday - Saturday 06:00 NZ


  • "Street Signs" Co-Anchor

  • Co-anchor of CNBC's "Street Signs," Amanda Drury is based at the network's global headquarters in Englewood Cliffs, N.J.